University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 4B-08-1


 
Description: Randomized Study of Larotaxel + Cisplatin (LC) vs. Gemcitabine + Cisplatin (GC) in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer.
Status: Open
Randomized? Yes


Researchers  
Principal InvestigatorTitle
David QuinnM.D.

Data Management
NameTitle
Charlean KetchensR.N.
Lagrimas IlaganD.M.
Roberto TejadaD.M.
Carrie KornR.N.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.